PHARMACEUTICAL COMPOSITION FOR PREVENTING DRUG ABUSE BY PPRODUCING MUSOUS MEMBRANE IRRITATION

Details for Australian Patent Application No. 2002356089 (hide)

Owner NOVARTIS AG

Inventors JOSHI, Yatindra; SOMMA, Russell

Pub. Number AU-A-2002356089

PCT Number PCT/EP02/09660

PCT Pub. Number WO2003/018015

Priority 09/942,809 30.08.01 US

Filing date 29 August 2002

Wipo publication date 10 March 2003

International Classifications

A61K 031/4458 - only substituted in position 2, e.g. methylphenidate

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 047/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 09/942,809 30.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002356089

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356090-USE OF HLA CLASS 1 SOLUBLE MOLECULES TO INHIBIT ANGIOGENESIS

2002356088-WATER-INSOLUBLE, ANTIMICROBIAL SILICATE GLASS AND USE THEREOF